© 2014

Tumor Dormancy, Quiescence, and Senescence, Volume 2

Aging, Cancer, and Noncancer Pathologies

  • M.A. Hayat
  • Role of Dormancy in various cancer types is explained

  • Role of Senescence in the aging process is also included

  • Mechanisms underlying premature cellular senescence is detailed

  • The discussion in chapters is reinforced by color figures and Tables


Part of the Tumor Dormancy and Cellular Quiescence and Senescence book series (DOQU, volume 2)

Table of contents

  1. Front Matter
    Pages i-xxvii
  2. Molecular Mechanisms

    1. Front Matter
      Pages 1-1
    2. Fotunato Scalera, Stefanie M. Bode-Böger
      Pages 3-16
    3. Vincenzo Cantaluppi, Federico Figliolini, Maria Chiara Deregibus, Giovanni Camussi
      Pages 17-25
    4. Guocan Wang, Yuan Gao, Li Chen, Ying-Jan Wang, Hui-Kuan Lin
      Pages 33-43
    5. Olga Moiseeva, Gerardo Ferbeyre
      Pages 45-52
    6. Christiaan H. Righolt, Vered Raz
      Pages 61-69
    7. Li Wei Ma, Guo Dong Li, Tan Jun Tong
      Pages 71-80
    8. Julien Maizel, Jun Chen, Michael S. Goligorsky
      Pages 121-128
  3. Tumor and Cancer

    1. Front Matter
      Pages 129-129
    2. Umberto Galderisi, Gianfranco Peluso
      Pages 143-153
    3. Lara H. El Touny, Dalit Barkan, Jeffrey E. Green
      Pages 155-164

About this book


In this second volume in the series exploring Tumor Dormancy, Quiescence, and Cellular Senescence, discussion is focused on the role of tumor dormancy in diseases such as breast cancer, melanoma, prostate cancer, liver cancer and lung cancer. M. A. Hayat, the series editor, writes in the preface that little is known of factors regulating the transition of residual cancer into a dormant state or the subsequent reinitiation of growth. A majority of us, he says, have in situ tumors that may remain dormant or may progress into a lethal form of cancer; the former are prevented from recruiting their own blood supply.


Section I covers Molecular Mechanisms, with chapters on the role of NAE inhibitor MLN4924; oncogene-induced senescence; the role played by mitogen-activated protein kinase in the induction of cellular senescence; mechanisms of premature cell senescence and other topics. Section II examines Tumor and Cancer, discussing defects in chromatin structure and diseases; the role of fibrosis in tumor progression and the dormant to proliferative switch; the function of ING proteins in cancer and senescence and more. The final section is devoted to Stem Cells and Cancer Stem Cells, featuring chapters showing that senescent-derived pluripotent stem cells are able to redifferentiate into fully rejuvenated cells; that the transcription factor Gata2 regulates quiescence in haematopoietic stem and progenitor cells; and discussing dormancy and recurrence of cancer stem cells in bone.


The contributors point out that the quiescent state regulates hematopoietic stem cells and muscle stem cells, and detail the role of kinase in the mediation of reversible quiescent state in a subset of ovarian, pancreatic, and colon cancers. Molecular mechanisms underlying stress-induced cellular senescence and accumulation of reactive oxygen species and induction of premature senescence are also presented. Discussion includes the important role of microRNAs in oxidative stress-induced apoptosis and senescence and the effect of microRNA as a modulator of cell proliferation in lung cancer. The book includes an explanation of the suppression of cellular senescence in glioblastoma brain tumor.


Taking a broad and varied perspective, this volume was written by 70 contributors representing 11 countries.


Cancer Stem cells and dormancy Cancer diagnosis Senescent-derived pluripotent stem cells Therapeutic application of cellular dormancy Tissue regeneration in disease

Editors and affiliations

  • M.A. Hayat
    • 1
  1. 1.Department of Biological SciencesKean University, Room 213, Library BuildingUnionUSA

Bibliographic information

Industry Sectors
Chemical Manufacturing
Consumer Packaged Goods